What does Vor Biopharma Inc. do?
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as…
What is Vor Biopharma Inc.'s P/E and P/B ratio?
Vor Biopharma Inc. has a P/E ratio of 0.1 and a P/B ratio of -5.60.
What is Vor Biopharma Inc.'s debt-to-equity ratio?
Vor Biopharma Inc. has a debt-to-equity ratio of -0.02.
How much does Vor Biopharma Inc. owe compared with what it owns?
Vor Biopharma Inc. owes $1.42 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Vor Biopharma Inc.'s Positivity rank?
Vor Biopharma Inc. is ranked #6,445 of 6,774 companies globally and #3,704 of 4,000 in United States on PositoAI, with a Positivity Score of -19,751.
Does Vor Biopharma Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Vor Biopharma Inc..
Where can I read the latest news about Vor Biopharma Inc.?
Recent headlines about Vor Biopharma Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Vor Biopharma Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Vor Biopharma Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.